ERBB3 and breast cancer: Using online tools [27,28], we noted that high mRNA expression of both JAM-A and HER3 is observed in invasive breast carcinomas (Figure S2a,b respectively), and their coincident high expression is associated with reduced recurrence-free survival in breast cancer patients (Figure S2c).